Mitigating effects of vaccination on influenza outbreaks given constraints in stockpile size and daily administration capacity

Abstract

BackgroundInfluenza viruses are a major cause of morbidity and mortality worldwide. Vaccination remains a powerful tool for preventing or mitigating influenza outbreaks. Yet, vaccine supplies and daily administration capacities are limited, even in developed countries. Understanding how such constraints can alter the mitigating effects of vaccination is a crucial part of influenza preparedness plans. Mathematical models provide tools for government and medical officials to assess the impact of different vaccination strategies and plan accordingly. However, many existing models of vaccination employ several questionable assumptions, including a rate of vaccination proportional to the population at each point in time.MethodsWe present a SIR-like model that explicitly takes into account vaccine supply and the number of vaccines administered per day and places data-informed limits on these parameters. We refer to this as the non-proportional model of vaccination and compare it to the proportional scheme typically found in the literature.ResultsThe proportional and non-proportional models behave similarly for a few different vaccination scenarios. However, there are parameter regimes involving the vaccination campaign duration and daily supply limit for which the non-proportional model predicts smaller epidemics that peak later, but may last longer, than those of the proportional model. We also use the non-proportional model to predict the mitigating effects of variably timed vaccination campaigns for different levels of vaccination coverage, using specific constraints on daily administration capacity.ConclusionsThe non-proportional model of vaccination is a theoretical improvement that provides more accurate predictions of the mitigating effects of vaccination on influenza outbreaks than the proportional model. In addition, parameters such as vaccine supply and daily administration limit can be easily adjusted to simulate conditions in developed and developing nations with a wide variety of financial and medical resources. Finally, the model can be used by government and medical officials to create customized pandemic preparedness plans based on the supply and administration constraints of specific communities.

Efficient Vaccine Distribution Based on a Hybrid Compartmental Model

“…These studies can be categorised into two subtypes. Studies of the first subtype have attempted to investigate the effects of different vaccine distribution strategies on disease control [ 54 ]–[ 58 ]. For example, Hsieh [ 54 ] explored vaccination strategies by taking age groups and intervention measures into account.…”

Impacts of constrained culling and vaccination on control of foot and mouth disease in near-endemic settings: A pair approximation model

“…The disease agent which causes FMD belongs to the picorna virus family (Belsham et al, 2011;Dion et al, 2011), and it exists in seven known immunologically distinct serotypes which vary according to world geographical location (Rweyemamu, 1984; cordon fences erected to divide a country into multiple subregions to prevent movement of animals across the borders); public education; quarantine; vaccination and culling (Barteling, 2002). Control measures of FMD need to take into account the natural characteristics of the virus, mechanism of spread, as well as strategic implementation based on available resources (Cruz-Aponte et al, 2011;Roy et al, 2011). Because of their greater resources, most developed countries have managed to contain, eradicate and avoid importation of FMD virus into their territories.…”

Biosafety risk assessment for production of candidate vaccine viruses to protect humans from zoonotic highly pathogenic avian influenza viruses

“…Vaccination is the principal public health intervention to mitigate an emerging pandemic. Effective pandemic mitigation depends on achieving high vaccination coverage before the pandemic virus becomes widespread . The efficacy of licensed influenza vaccines depends on a high level of structural similarity between the hemagglutinins (HA) of vaccine and circulating viruses.…”